Amarin Corp. (AMRN) Tops Q3 EPS by 7c
Tweet
Share
E-mail
Get Alerts AMRN Hot Sheet
Price: $14.15 --0%
Financial Fact:
Research and development: 13.49M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Research and development: 13.49M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Amarin Corp. (NASDAQ: AMRN) reported Q3 EPS of $0.03, $0.07 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $142 million versus the consensus estimate of $161.29 million.
For earnings history and earnings-related data on Amarin Corp. (AMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
